Late neurocognitive sequelae in patients with WHO grade I meningioma

Journal of Neurology, Neurosurgery and Psychiatry

Volumn 80, Issue 8, 2009, Pages 910-915

  Dijkstra, M ^a   Van Nieuwenhuizen, D ^a   Stalpers, L J A ^b   Wumkes, M ^b   Waagemans, M ^a   Vandertop, W P ^a,c   Heimans, J J ^a   Leenstra, S ^c   Dirven, C M ^d   Reijneveld, J C ^a,b   Klein, M ^a  

^a VU UNIVERSITY MEDICAL CENTER   (Netherlands)

^b ACADEMIC MEDICAL CENTER   (Netherlands)

^c TweeSteden Hospital   (Netherlands)

^d ERASMUS MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ANTICONVULSIVE AGENT; CARBAMAZEPINE; CLONAZEPAM; ETIRACETAM; GABAPENTIN; OXCARBAZEPINE; PHENYTOIN; TOPIRAMATE; VALPROIC ACID;

ADULT; AMNESIA; ARTICLE; CANCER ADJUVANT THERAPY; CANCER PATIENT; CANCER RADIOTHERAPY; CANCER SURGERY; CASE CONTROL STUDY; COGNITION; COGNITIVE DEFECT; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE SEVERITY; EPILEPSY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MENINGIOMA; MENTAL FUNCTION; MORBIDITY; PATIENT ASSESSMENT; PRIORITY JOURNAL; PSYCHOMOTOR ACTIVITY; SEIZURE; SKULL BASE; TUMOR LOCALIZATION; TUMOR VOLUME; VERBAL MEMORY; WORKING MEMORY; WORLD HEALTH ORGANIZATION; AGED; CLINICAL TRIAL; CROSS-SECTIONAL STUDY; HEMISPHERIC DOMINANCE; MIDDLE AGED; MULTICENTER STUDY; NEUROPSYCHOLOGICAL TEST; NEUROSURGERY; PHYSIOLOGY; PSYCHOLOGICAL ASPECT; PSYCHOMOTOR PERFORMANCE; SOCIOECONOMICS; TUMOR RECURRENCE;

ADULT; AGED; AGED, 80 AND OVER; COGNITION DISORDERS; CROSS-SECTIONAL STUDIES; EPILEPSY; FEMALE; FUNCTIONAL LATERALITY; HUMANS; MALE; MENINGIOMA; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; NEUROPSYCHOLOGICAL TESTS; NEUROSURGICAL PROCEDURES; PSYCHOMOTOR PERFORMANCE; SOCIOECONOMIC FACTORS; YOUNG ADULT;

EID: 67849118876     PISSN: 00223050     EISSN: 1468330X     Source Type: Journal    
DOI: 10.1136/jnnp.2007.138925     Document Type: Article

References (32)

1. Longstreth WT Jr, Dennis LK, McGuire VM, et al. Epidemiology of intracranial meningioma. Cancer 1993;72:639-48.
2. Louis DN, Scheithauer BW, Budka H, et al. In: Kleihues P, Cavenee WK, eds. World Health Organization Classification of Tumours. Pathology and genetics of tumours of the nervous system. Lyon: IARC Press, 2000:176-84.
3. Lieu AS, Howng SL. Intracranial meningiomas and epilepsy: incidence, prognosis and influencing factors. Epilepsy Res 2000;38:45-52.
4. Whittle IR, Smith C, Navoo P, et al. Meningiomas. Lancet 2004;363:1535-43.
5. Barbaro NM, Gutin PH, Wilson CB, et al. Radiation therapy in the treatment of partially resected meningiomas. Neurosurgery 1987;20:525-8.
6. Goldsmith BJ, Wara WM, Wilson CB, et al. Postoperative irradiation for subtotally resected meningiomas. A retrospective analysis of 140 patients treated from 1967 to 1990. J Neurosurg 1994;80:195-201.
7. Jaaskelainen J. Seemingly complete removal of histologically benign intracranial meningioma: late recurrence rate and factors predicting recurrence in 657 patients. A multivariate analysis. Surg Neurol 1986;26:461-9.
8. Kokubo M, Shibamoto Y, Takahashi JA, et al. Efficacy of conventional radiotherapy for recurrent meningioma. J Neurooncol 2000;48:51-5.
9. Duchstein S, Gademann G, Peters B. Early and late effects of local high dose radiotherapy of the brain on memory and attention. Strahlenther Onkol 2003;179:441-51.
10. Dufour H, Muracciole X, Metellus P, et al. Long-term tumor control and functional outcome in patients with cavernous sinus meningiomas treated by radiotherapy with or without previous surgery: is there an alternative to aggressive tumor removal? Neurosurgery 2001;48:285-94.
11. Mathiesen T, Kihlstrom L, Karlsson B, et al. Potential complications following radiotherapy for meningiomas. Surg Neurol 2003;60:193-8.
12. Klein M, Engelberts NH, van der Ploeg HM, et al. Epilepsy in low-grade gliomas: the impact on cognitive function and quality of life. Ann Neurol 2003;54:514-20.
13. Taphoorn MJ, Klein M. Cognitive deficits in adult patients with brain tumours. Lancet Neurol 2004;3:159-68.
14. Jolles J, van Boxtel MP, Ponds RW, et al. The Maastricht aging study (MAAS). The longitudinal perspective of cognitive aging. Tijdschr Gerontol Geriatr 1998;29:120-9.
15. Schmand B, Bakker D, Saan R, et al. The Dutch Reading Test for Adults: a measure of premorbid intelligence level. Tijdschr Gerontol Geriatr 1991;22:15-19.
16. Stewart AL, Ware JE Jr. Measuring functioning and well-being: The medical outcomes study approach. Durham, NC: Duke University Press, 1992.
17. Order SE, Hellman S, Von Essen CF, et al. Improvement in quality of survival following whole-brain irradiation for brain metastasis. Radiology 1968;91:149-53.
18. Karnofsky DA, Abelmann WH, Craver LF. The use of nitrogen mustards in the palliative treatment of carcinoma. Cancer 1948;1:634-56.
19. Wade DT, Collin C. The Barthel ADL Index: a standard measure of physical disability? Int Disabil Stud 1988;10:64-7.
20. Osoba D, Aaronson NK, Muller M, et al. The development and psychometric validation of a brain cancer quality-of-life questionnaire for use in combination with general cancer-specific questionnaires. Qual Life Res 1996;5:139-50.
21. Benton AL. Differential behavioral effects in frontal lobe disease. Neuropsychologia 1968;6:53-60.
22. Houx PJ, Jolles J. Vulnerability factors for age-related cognitive decline. In: Isaacson RL, Jensen KF, eds. The vulnerable brain and environmental risks. New York: Plenum Press, 1994:25-41.
23. Lezak MD. Neuropsychological assesment. New York: Oxford University Press, 2004.
24. Wechsler D. Wechsler Adult Intelligence Scale III. San Antonio, TX: The Psychological Corporation, 1997.
25. Tucha O, Smely C, Preier M, et al. Cognitive deficits before treatment among patients with brain tumors. Neurosurgery 2000;47:324-33.
26. Tucha O, Smely C, Preier M, et al. Preoperative and postoperative cognitive functioning in patients with frontal meningiomas. J Neurosurg 2003;98:21-31.
27. Jurado MB, Rosselli M. The elusive nature of executive functions: a review of our current understanding. Neuropsychol Rev 2007;17:213-33.
28. Alvarez JA, Emory E. Executive function and the frontal lobes: a meta-analytic review. Neuropsychol Rev 2006;16:17-42.
29. Meador KJ. Newer anticonvulsants: dosing strategies and cognition in treating patients with mood disorders and epilepsy. J Clin Psychiatry 2003;64(Suppl 8):30-4.
30. Klein M, Heimans JJ, Aaronson NK, et al. Effect of radiotherapy and other treatment-related factors on mid-term to long-term cognitive sequelae in low-grade gliomas: a comparative study. Lancet 2002;360:1361-8.
31. Yasargil MG. Meningiomas. In: Yasargil MG, ed. Microneurosurgery IVB: microneurosurgery of CNS tumors. Stuttgart: Thieme Verlag, 1996:134-85.
32. van Nieuwenhuizen D, Klein M, Stalpers LJ, et al. Differential effect of surgery and radiotherapy on neurocognitive functioning and health-related quality of life in WHO grade I meningioma patients. J Neurooncol 2007;84:271-8.